Skip to main content

VACCELERATE - European Corona Vaccine Trial Accelerator Platform

Objective

The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is continued need for phase 2 & 3 vaccine trials to reach long-term, large-scale immunity of the entire European population.
VACCELERATE will be the pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials. The overall objective of VACCELERATE is to connect all European stakeholders involved in vaccine development to provide a pan-European platform for clinical trial design and conduct. VACCELERATE constitutes the rapid response single entry-point to stakeholders from public health authorities to vaccine developers, to address respective needs and kick-start specifically phase 2 & 3 vaccine trials.
VACCELERATE conducts capacity mapping of clinical trial and laboratory sites to identify suitable sites for individual phase 2 & 3 vaccine trials. Capacity building via training will increase quality in sites across Europe. Volunteer registries facilitate patient recruitment. Access to laboratory sites and a standardised set of assays essential for clinical phase 2 & 3 trials is provided. A harmonised European approach to vaccine trials is enabled by aligning educational standards, coordination of laboratory support and providing standardised assays and trial protocols. Harmonised data collection, open data sharing and pooling of data for stronger analysis enables data standardisation. VACCELERATE offers solutions for characteristic vaccine development issues during pandemics by closing gaps in public health knowledge and improving knowledge transfer.
VACCELERATE amalgamates the vast but scattered expertise across Europe into one network to deliver strategic scientific leadership and guidance on vaccine trials in Europe. Beyond the COVID-19 pandemic, it will be an established pandemic preparedness network, ready to face emerging future pandemics, as well as a pivot in Europe?s capacity to develop vaccines.

Call for proposal

H2020-IBA-SC1-CORONAVIRUS-2020-4
See other projects for this call

Coordinator

KLINIKUM DER UNIVERSITAET ZU KOELN
Address
Kerpener Strasse 62
50937 Koeln
Germany
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 2 412 013,75

Participants (25)

BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED
Slovakia
EU contribution
€ 92 361,25
Address
Dubravska Cesta 9
845 05 Bratislava
Activity type
Research Organisations
CENTRO HOSPITALAR UNIVERSITARIO DO PORTO EPE
Portugal
EU contribution
€ 292 120
Address
Largo Professor Abel Salazar
4099 001 Porto
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
KENTRO KLINIKIS EPIDIMIOLOGIAS KAI EKVASIS NOSIMATON
Greece
EU contribution
€ 342 188,75
Address
Xatzigianni Meksi 5
11528 Athina
Activity type
Research Organisations
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
France
EU contribution
€ 405 125
Address
5 Rue Watt
75013 Paris
Activity type
Research Organisations
EUROPEAN UNIVERSITY CYPRUS
Cyprus
EU contribution
€ 537 612,50
Address
Diogenes Street 6 Engomi
1516 Nicosia
Activity type
Higher or Secondary Education Establishments
EUROPEAN VACCINE INITIATIVE EWIV
Germany
EU contribution
€ 568 992,50
Address
Vossstrasse 2 Geb 4040
69115 Heidelberg
Activity type
Research Organisations
HACETTEPE UNIVERSITESI
Turkey
EU contribution
€ 183 706,25
Address
Hacettepe Universitesi Beytepe Kampusu Rektorluk Binasi
06800 Cankaya Ankara
Activity type
Higher or Secondary Education Establishments
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 592 603,75
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
INSTITUTO DE SALUD CARLOS III
Spain
EU contribution
€ 983 043,75
Address
Monforte De Lemos 5
28029 Madrid
Activity type
Research Organisations
KAROLINSKA INSTITUTET
Sweden
EU contribution
€ 344 807,50
Address
Nobels Vag 5
17177 Stockholm
Activity type
Higher or Secondary Education Establishments
REGION STOCKHOLM
Sweden
EU contribution
€ 329 246,25
Address
Hantverkargatan 45
104 22 Stockholm
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
FACULTY OF MEDICINE, UNIVERSITY OF BELGRADE
Serbia
EU contribution
€ 92 361,25
Address
Dr Subotica, 8
11000 Belgrade
Activity type
Higher or Secondary Education Establishments
MINISTRY OF HEALTH
Israel
EU contribution
€ 223 611,25
Address
Yirmiyahu 39
9101002 Jerusalem
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
UNIWERSYTET MEDYCZNY W BIALYMSTOKU
Poland
EU contribution
€ 106 111,25
Address
Jana Kilinskiego 1
15-089 Bialystok
Activity type
Higher or Secondary Education Establishments
MEDIZINISCHE UNIVERSITAET WIEN
Austria
EU contribution
€ 92 361,25
Address
Spitalgasse 23
1090 Wien
Activity type
Higher or Secondary Education Establishments
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Ireland
EU contribution
€ 886 111,25
Address
Belfield
4 Dublin
Activity type
Higher or Secondary Education Establishments
NATIONAL UNIVERSITY OF IRELAND GALWAY
Ireland
EU contribution
€ 106 152,50
Address
University Road
H91 Galway
Activity type
Higher or Secondary Education Establishments
REGION HOVEDSTADEN
Denmark
EU contribution
€ 381 783,75
Address
Kongens Vaenge 2
3400 Hillerod
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
UNIVERSITEIT ANTWERPEN
Belgium
EU contribution
€ 1 225 232,50
Address
Prinsstraat 13
2000 Antwerpen
Activity type
Higher or Secondary Education Establishments
UNIVERSITAET BERN
Switzerland
EU contribution
€ 139 027,50
Address
Hochschulstrasse 6
3012 Bern
Activity type
Higher or Secondary Education Establishments
UNIVERSITETET I BERGEN
Norway
EU contribution
€ 661 032,50
Address
Museplassen 1
5020 Bergen
Activity type
Higher or Secondary Education Establishments
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands
EU contribution
€ 555 168,75
Address
Heidelberglaan 100
3584 CX Utrecht
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI VERONA
Italy
EU contribution
€ 92 361,25
Address
Via Dell Artigliere 8
37129 Verona
Activity type
Higher or Secondary Education Establishments
UNIVERSITE DE PARIS
France
EU contribution
€ 262 500
Address
85 Bd Saint Germain
75006 Paris
Activity type
Higher or Secondary Education Establishments
VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS
Lithuania
EU contribution
€ 92 361,25
Address
Santariskiu G 2
08661 Vilnius
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)